Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1981 Jul;57(669):436-8.
doi: 10.1136/pgmj.57.669.436.

A double-blind controlled trial of the effect of sodium cromoglycate in preventing relapse in ulcerative colitis

P J Whorwell, G M Whorwell, J Bamforth, D Colin Jones, P Down, A Edwards, A E Gent, P Golding, K R Gough, M D Hellier, P Isaacson, C A Loehry, G J Milton-Thompson, C L Smith, R P Waldram, R Wright
Clinical Trial

A double-blind controlled trial of the effect of sodium cromoglycate in preventing relapse in ulcerative colitis

P J Whorwell et al. Postgrad Med J. 1981 Jul.

Abstract

A double-blind controlled trial of the effect of sodium cromoglycate (SCG) in preventing relapse in ulcerative colitis has been completed in 100 subjects. In patients already taking sulphasalazine, SCG did not prove to be of any additional benefit. However, in patients not on any other maintenance therapy, the relapse rate was 40% for SCG as compared with 75% for placebo. A large study of the effect of SCG in patients intolerant of sulphasalazine is indicated.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Gut. 1973 Dec;14(12):923-6 - PubMed
    1. Gut. 1975 Jul;16(7):559-63 - PubMed
    1. Lancet. 1976 Feb 28;1(7957):439-41 - PubMed
    1. Gut. 1980 Mar;21(3):232-40 - PubMed
    1. Gut. 1978 Dec;19(12):1136-9 - PubMed

Publication types